Abstract
This study explored the impact of comorbidity on symptom severity and treatment outcome in a sample of 75 pediatric Obsessive–Compulsive Disorder (OCD) patients. Forty received cognitive–behavioral therapy (CBT). Overall, 56% had a comorbid disorder. Results revealed that youth with comorbid disorders (anxiety or otherwise) endorsed significantly more anxiety symptoms than youth with OCD only. Youth with comorbidities instead of or in addition to anxiety exhibited more severe OCD symptoms than youth with OCD alone or an anxiety-only comorbidity. Youth in the comorbidities instead of or in addition to anxiety group had the poorest CBT response relative to the other groups. These results suggest that relative to those with OCD alone or with an anxiety disorder comorbidity, youth with comorbidities instead of or in addition to anxiety have a differing clinical presentation (e.g., more severe symptoms) and worse psychotherapy outcome.
Similar content being viewed by others
Notes
Percentages are over 100% due to several individuals diagnosed with multiple comorbid conditions.
References
Achenbach, T. M. (1991). Manual for the child behavior checklist/4-18 and 1991 profile. Burlington, VT: University of Vermont, Department of Psychiatry.
Calvocoressi, L., Lewis, B., Harris, M., Trufan, S. J., Goodman, W. K., McDougle, C. J. et al. (1995). Family accommodation in obsessive compulsive disorder. American Journal of Psychiatry, 152, 441–443.
Calvocoressi, L., Mazure, C., Kasl, S. V., Skolnick, J., Fisk, D., Vegso, S. J. et al. (1999). Family accommodation of obsessive–compulsive symptoms: Instrument development and assessment of family behavior. Journal of Nervous and Mental Disease, 187, 636–642.
Carter, A. S., Pollock, R. A., Suvak, M. K., & Pauls, D. L. (2004). Anxiety and major depression comorbidity in a family study of obsessive–compulsive disorder. Depression and Anxiety, 20, 165–174.
Geffken, G. R., Storch, E. A., Duke, D., Lewin, A., Monaco, L., & Goodman, W. K. (2006). Hope and coping in family members of patients with obsessive compulsive disorder. Journal of Anxiety Disorders, 20, 614–629.
Geller, D. A., Biederman, J., Griffin, S., Jones, J., & Lefkowitz, T. R. (1996). Comorbidity of juvenile obsessive–compulsive disorder with disruptive behaviour disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1637–1646.
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrel, C., Wagner, K. D. et al. (2003a). Impact of comorbidity on treatment response to paroxetine in pediatric obsessive–compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child and Adolescent Psychopharmacology, 13, S19–S29.
Geller, D. A., Coffey, B., Faraone, S., Hagermoser, L., Zaman, N. K., Farrell, C. L. et al. (2003b). Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive–compulsive disorder? CNS Spectrums, 8, 259–264.
Geller, D. A., Biederman, J., Faraone, S., Agranat, A., Cradock, K., Hagermoser, L. et al. (2001). Developmental aspects of obsessive compulsive disorder: Findings in children, adolescents, and adults. Journal Nervous Mental Disorders, 189, 471–477.
Guy, W. (1976). Assessment manual for psychopharmacology, revised (DHEW Publication ABM 76-366). Washington DC: US Government Printing Office.
Hanna, G. L., Yuwiler, A., & Coates, J. K. (1995). Whole blood serotonin and disruptive behaviors in juvenile obsessive–compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 28–35.
Kovacs, M. (1992). The children’s depression inventory. Manual. Toronto, Ontario, Canada: Multi-Health Systems, Inc.
Ledley, D. R., Pai, A., & Franklin, M. E. (2007). Treating comorbid presentations: Obsessive compulsive disorder, anxiety disorders, and depression. In M. Antony, C. Purdon, & L. J. Summerfeldt (Eds.). Psychological treatment of obsessive–compulsive disorder: Fundamentals and beyond (pp 281–293). Washington, DC.: American Psychological Association.
March, J. S., Parker, J. D., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children: Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 554–565.
March, J. S, Sullivan, K., & Parker, J. D. (1999). Test–retest reliability of the Multidimensional Anxiety Scale for Children. Journal of Anxiety Disorders, 13, 349–358.
Masi, G., Perugi, G., Toni, C., Millepiedi, S., Mucci, M., Bertini, N.et al. (2004). Obsessive–compulsive bipolar comorbidity: Focus on children and adolescents. Journal of Affective Disorders, 78, 175–183.
Masi, G., Millepiedi, S., Mucci, M., Bertini, N., Pfanner, C., & Arcangeli, F. (2006). Comorbidity of obsessive–compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Comprehensive Psychiatry, 46, 42–47.
National Institute of Mental Health (1985). Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin, 21, 839–843.
Pediatric Obsessive–Compulsive Disorder Treatment Study Team (2004). Cognitive–behavioral therapy, sertraline, and their combination for children and adolescents with obsessive–compulsive disorder: The Pediatric Obsessive–Compulsive Disorder Treatment Study (POTS) Randomized Controlled Trial. Journal of the American Medical Association, 292, 1969–1976.
Piacentini, J. C., Bergman, R. L., Keller, M., & McCracken, J. (2003). Functional impairment in children and adolescents with obsessive–compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13, S61–S69.
Rasmussen, S. A., & Tsuang, M. T. (1986). Clinical characteristics and family history in DSM-III obsessive–compulsive disorder. American Journal of Psychiatry, 143, 317–322.
Rasmussen, S. A., & Eisen, J. L. (1988). Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacology Bulletin, 24, 466–470.
Riddle, M. A., Hardin, M. T., King, R., Scahill L., & Woolston, J. L. (1990). Fluoxetine treatment of children and adolescents with Tourette’s and obsessive compulsive disorders: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 45–48.
Rufer, M., Grothusen, A., Mass, R., Peter, J., & Hand, I. (2005). Temporal stability of symptom dimensions in adult patients with obsessive–compulsive disorder. Journal of Affective Disorders, 88, 99–102.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K. et al. (1997). Children’s Yale–Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–852.
Silverman, W. K., & Albano, A. M. (1996). The anxiety disorders interview schedule for DSM-IV: Child and parent versions. San Antonio, TX: Psychological Corporation.
Silverman, W. K., Saavedra, L. M., & Pina, A. A. (2001). Test–retest reliability of anxiety symptoms and diagnoses with anxiety disorders interview schedule for DSM-IV: Child and parent versions. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 937–944.
Storch, E. A., Murphy, T. K., Geffken, G. R., Soto, O., Sajid, M., Allen, P. et al. (2004). Psychometric evaluation of the Children’s Yale–Brown Obsessive Compulsive Scale. Psychiatry Research, 129, 91–98.
Storch, E. A., Geffken, G. R., Merlo, L. J., Mann, G., Duke, D., Munson, M. et al. (2007a). Cognitive–behavioral therapy for pediatric obsessive–compulsive disorder: Comparison of intensive and weekly approaches. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 469–478.
Storch, E. A., Merlo, L. J., Larson, M. J., Fernandez, M., Jacob, M. L., Geffken, G. R. et al. (2007b). Family accommodation in pediatric obsessive–compulsive disorder. Journal of Clinical Child and Adolescent Psychology, 36, 207–216.
Sukhodolsky, D. G., Do Rosario-Campos, M. C., Scahill, L., Katsovich, L., Pauls, D. L., Peterson, B. S. et al. (2005). Adaptive, emotional, and family functioning of children with obsessive–compulsive disorder and comorbid attention deficit hyperactivity disorder. American Journal of Psychiatry, 162, 1125–1132.
Swedo, S. E., Rapoport, J. L., Leonard, H., Lenane, M., & Cheslow, D. (1989). Obsessive–compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Archives of General Psychiatry, 46, 335–341.
Termine, C., Balottin, U., Rossi, G., Maisano, F., Salini, S., Di Nardo, R. et al. (2006). Psychopathology in children and adolescents with Tourette’s syndrome: A controlled study. Brain and Development, 28, 69–75.
Tükel, R., Polat, A., Özdemir, Ö., Aksüt, D., & Türksoy, N. (2002) Comorbid conditions in obsessive–compulsive disorder. Comprehensive Psychiatry, 43, 204–209.
Weissman, M. M., Bland, R. C., Canino, G. J., Greenwald, S., Hwu, H. G., Lee, C. K. et al. (1994). The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. Journal of Clinical Psychiatry, 55, 5–10.
Wood, J. J., Piacentini, J. C., Bergman, R. L., McCracken, J., & Barrios, V. (2002). Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: Child and parent versions. Journal of Clinical Child and Adolescent Psychology, 31, 335–342.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Storch, E.A., Larson, M.J., Merlo, L.J. et al. Comorbidity of Pediatric Obsessive–Compulsive Disorder and Anxiety Disorders: Impact on Symptom Severity and Impairment. J Psychopathol Behav Assess 30, 111–120 (2008). https://doi.org/10.1007/s10862-007-9057-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10862-007-9057-x